Now online: English information about CBG-ZIN Parallel Procedures Pilot
As previously highlighted in our newsletter, the Dutch Medicines Evaluation Board (CBG-MEB) and the National Health Care Institute (Zorginstituut Nederland: ZIN) joined forces in a pilot to accelerate access to innovative medicines in the Netherlands. To inform your international colleagues and/or international affiliates about this opportunity, the information about the “CBG-ZIN Parallel Procedures pilot” is now available online.
Recently, HollandBIO and the Association of Innovative Medicines organized together with CBG-MEB and ZIN a well-attended information session about the pilot, during which Kevin Liebrand (project lead on behalf of CBG-MEB) and Pauline Pasman (project lead on behalf of ZIN) elaborated on the aim of the pilot and the prerequisites for participation. Companies were very enthusiastic about the pilot, based on the amount of questions that were asked during the session. Frequently asked questions will be combined and published online in the near future.
The pilot is a seamless fit with the HollandBIO program Faster & better from bench to bedside, where we work towards solutions that boost both health, innovation and affordability. This pilot is a first step towards a more flexible health ecosystem, where the Netherlands can achieve the full potential of tomorrow’s medicines. We are therefore very curious who will be the frontrunner of this faster & better opportunity.
The most important information about the pilot can be found here, including a link to the Interest Form – CBG-ZIN Parallel Procedures pilot. Explanation in English of the interest form can be found here. If you have any questions, you can also always contact Marit.